Explore by goal
Explore clinician-guided pain and inflammation pathways, including low-dose naltrexone and select recovery programs when appropriate.
What to consider
Explore clinician-guided pain and inflammation pathways, including low-dose naltrexone and select recovery programs when appropriate.
1 program
Persistent pain deserves a thoughtful plan. Low-dose naltrexone is studied for pain, including fibromyalgia, and selected inflammatory conditions. A clinician reviews your goals, the formula and individual suitability.
Medication, shipping, clinician review and ongoing support included.
Explore programConsider This
FAQ
No. Naltrexone is FDA approved for opioid- and alcohol-related indications at standard doses; low-dose use for chronic pain or inflammation-related conditions is off label.
Naltrexone blocks opioid receptors and can create serious problems for people using opioid medications or with opioid dependence. A clinician must review all prescriptions, nonprescription products and recent opioid exposure.
The evidence is evolving and varies by condition. A recent randomized-trial meta-analysis found mixed results overall, with a signal in fibromyalgia but increased adverse events versus placebo. It should not be marketed as a proven universal pain treatment.
No. New weakness, loss of bowel or bladder control, chest pain, severe injury, fever with pain or other red flags need urgent or in-person assessment.
Authoritative starting points
Private clinician review
Program pages are educational. Eligibility, treatment, route and availability are determined only after an independent clinical evaluation.
